Waterloo Capital’s Lucid Diagnostics LUCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.62K Buy
+11,484
New +$10.7K ﹤0.01% 666

Other funds holding LUCD

Waterloo Capital's LUCD Position: Q3 2026 in Review

Waterloo Capital opened a new position in Lucid Diagnostics (LUCD) in Q3 2026: 11,484 shares worth $8.62K. The stake represents ﹤0.01% of the portfolio and ranks #666 among its holdings.

115 funds tracked by Wall St. Rank hold LUCD as of Q3 2026.

  • Waterloo Capital held 11,484 shares of Lucid Diagnostics worth $8.62K as of Q3 2026.
  • Lucid Diagnostics was a new Waterloo Capital position in Q3 2026.
  • Lucid Diagnostics made up ﹤0.01% of Waterloo Capital's portfolio in Q3 2026, its #666 holding.
  • 115 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2026.

Based on Waterloo Capital's 13F filing for Q3 2026, filed 16 Nov 2026.